Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)

China flag China · Delayed Price · Currency is CNY
6.67
-0.26 (-3.75%)
May 21, 2026, 3:04 PM CST
Market Cap3.85B +49.2%
Revenue (ttm)818.16M +6.8%
Net Income109.50M +120.8%
EPS0.19 +142.3%
Shares Out577.21M
PE Ratio34.89
Forward PEn/a
Dividend0.27 (3.81%)
Ex-Dividend DateMar 5, 2026
Volume12,491,560
Average Volume20,406,830
Open7.06
Previous Close6.93
Day's Range6.65 - 7.06
52-Week Range5.30 - 8.47
Beta0.41
RSI38.63
Earnings DateJul 24, 2026

About SHE:002107

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers Xinkeshu tablets, Naoxueshu oral solutions, Tongluo Huayu capsules, and oral liquids for cardiovascular and cerebrovascular; respiratory system drugs; medicines for women and children; urinary system drugs; digestive system drugs; anti-rheumatic drugs; and drugs for soothe the nerves. The company is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd. [Read more]

Sector Healthcare
Founded 2003
Employees 1,018
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002107
Full Company Profile

Financial Performance

In 2025, SHE:002107's revenue was 816.95 million, an increase of 6.96% compared to the previous year's 763.79 million. Earnings were 95.72 million, an increase of 162.93%.

Financial Statements